id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0488-0004,FDA,FDA-2011-P-0488,"FDA/CDER  to  Sandoz, Inc. - Response Letter",Other,Letter(s),2011-12-06T05:00:00Z,2011,12,2011-12-06T05:00:00Z,,2011-12-06T20:56:42Z,,0,0,0900006480f7c84c
FDA-2011-P-0488-0003,FDA,FDA-2011-P-0488,"Determination That Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TAXOTERE (Docetaxel) Injection, 40 Milligrams/Milliliter",Notice,General Notice,2011-11-28T05:00:00Z,2011,11,2011-11-28T05:00:00Z,,2011-11-28T14:59:00Z,2011-30472,0,0,0900006480f74452
FDA-2011-P-0488-0001,FDA,FDA-2011-P-0488,"Sandoz, Inc. - Citizen Petition",Other,Citizen Petition,2011-07-18T04:00:00Z,2011,7,2011-07-18T04:00:00Z,,2011-12-06T20:56:02Z,,0,0,0900006480e9c140
FDA-2011-P-0488-0002,FDA,FDA-2011-P-0488,"Acknowledgement Letter to Sandoz, Inc.",Other,Acknowledgement Letter/Receipt,2011-07-18T04:00:00Z,2011,7,2011-07-18T04:00:00Z,,2011-07-18T15:34:06Z,,0,0,0900006480e9c176